Reckitt Benckiser Group (LON:RB) received a GBX 6,300 ($82.87) target price from equities researchers at Goldman Sachs Group in a report issued on Monday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Goldman Sachs Group’s price objective indicates a potential upside of 2.77% from the company’s previous close.
Several other research firms also recently issued reports on RB. Jefferies Financial Group restated a “sell” rating and issued a GBX 5,000 ($65.77) price objective on shares of Reckitt Benckiser Group in a research note on Friday, November 15th. DZ Bank decreased their price objective on shares of Reckitt Benckiser Group from GBX 6,500 ($85.50) to GBX 6,000 ($78.93) and set a “hold” rating for the company in a research note on Thursday, October 31st. Sanford C. Bernstein set a GBX 7,600 ($99.97) target price on shares of Reckitt Benckiser Group and gave the company a “buy” rating in a report on Friday, October 18th. UBS Group raised shares of Reckitt Benckiser Group to a “hold” rating and reduced their target price for the company from GBX 6,500 ($85.50) to GBX 6,000 ($78.93) in a report on Wednesday, October 23rd. Finally, Barclays upped their target price on shares of Reckitt Benckiser Group from GBX 6,700 ($88.13) to GBX 7,000 ($92.08) and gave the company an “overweight” rating in a report on Wednesday, December 18th. Four equities research analysts have rated the stock with a sell rating, four have given a hold rating and nine have issued a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of GBX 6,692.35 ($88.03).
LON RB traded down GBX 61 ($0.80) during trading hours on Monday, hitting GBX 6,130 ($80.64). The company had a trading volume of 281,078 shares, compared to its average volume of 1,720,000. The company has a debt-to-equity ratio of 85.08, a quick ratio of 0.43 and a current ratio of 0.59. Reckitt Benckiser Group has a 1-year low of GBX 5,510 ($72.48) and a 1-year high of GBX 6,744 ($88.71). The company has a market cap of $43.94 billion and a PE ratio of 30.77. The business has a 50 day moving average of GBX 6,042.34 and a 200-day moving average of GBX 6,190.10.
In other news, insider Warren Tucker purchased 580 shares of the business’s stock in a transaction that occurred on Friday, October 25th. The stock was purchased at an average cost of GBX 5,810 ($76.43) per share, with a total value of £33,698 ($44,327.81).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with .